Pfizer Fact Sheet, Pfizer Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Pfizer Fact Sheet    (PFIZ)


REVEALED: Brijesh Bhatia's Private Telegram Channel (JOIN NOW)


Here is the latest financial fact sheet of Pfizer. For more details, see the Pfizer quarterly results and Pfizer share price and chart. For a sector overview, read our pharmaceuticals sector report.

PFIZER Price History

Price Rs 5,876.0
Mkt Cap Rs m 268,813
Vol '000 3.4
P/E X 46.9
P/CF X 44.3
EPS (TTM) Rs 125.3
% ch % -0.5
No. of shares m 45.75
% ch week % -2.2
% ch 1-mth % 3.0
% ch 12-mth % 33.6
52 week H/L Rs 6,107.7/4,200.0
(As on Aug 5, 2021 03:35:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

PFIZER Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
PFIZER EQUITY SHARE DATA
High Rs2,0552,3653,8404,9305,875 
Low Rs1,6511,6252,0802,7983,833 
Sales per share (Unadj.) Rs413.2427.7455.0470.3489.3 
Earnings per share (Unadj.) Rs73.678.793.8111.3108.8 
Diluted earnings per shareRs73.678.793.8111.3108.8 
Cash flow per share (Unadj.) Rs87.493.2109.4133.9132.7 
Dividends per share (Unadj.) Rs20.0020.0022.50330.0035.00 
Adj. dividends per shareRs20.0020.0022.50330.0235.00 
Dividend yield (eoy) %1.11.00.88.50.7 
Book value per share (Unadj.) Rs528.7586.5658.2742.2523.1 
Adj. book value per shareRs528.7586.5658.2742.2523.1 
Shares outstanding (eoy) m45.7545.7545.7545.7545.75 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x4.54.76.58.29.9 
Avg P/E ratio x25.225.331.634.744.6 
P/CF ratio (eoy) x21.221.427.128.936.6 
Price / Book Value ratio x3.53.44.55.29.3 
Dividend payout %27.225.424.0296.532.2 
Avg Mkt Cap Rs m84,77391,267135,413176,754222,063 
No. of employees `000NANANANANA 
Total wages/salary Rs m3,0393,1433,2383,6453,611 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
PFIZER INCOME DATA
Net Sales Rs m18,90619,56820,81521,51722,386 
Other income Rs m1,0121,1431,6741,840811 
Total revenues Rs m19,91820,71122,48923,35723,197 
Gross profit Rs m4,8065,0065,6565,7277,124 
Depreciation Rs m6296637141,0321,094 
Interest Rs m20817110154 
Profit before tax Rs m5,1685,4796,5996,4256,687 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,8011,8782,3091,3341,711 
Profit after tax Rs m3,3683,6014,2915,0914,976 
Gross profit margin %25.425.627.226.631.8 
Effective tax rate %34.834.335.020.825.6 
Net profit margin %17.818.420.623.722.2 
PFIZER BALANCE SHEET DATA
Current assets Rs m20,51324,16727,15430,48319,247 
Current liabilities Rs m7,7979,5448,9178,7347,743 
Net working cap to sales %67.374.787.6101.151.4 
Current ratio x2.62.53.03.52.5 
Inventory Days Days6366657075 
Debtors Days Days21293032 
Net fixed assets Rs m12,09712,73212,24613,56513,277 
Share capital Rs m458458458458458 
"Free" reserves Rs m23,73126,37529,65633,49723,473 
Net worth Rs m24,18926,83230,11333,95523,930 
Long term debt Rs m00000 
Total assets Rs m32,61036,90039,40044,04832,524 
Interest coverage x264.7712.6384.759.444.5 
Debt to equity ratio x00000 
Sales to assets ratio x0.60.50.50.50.7 
Return on assets %10.49.810.911.815.8 
Return on equity %13.913.414.215.020.8 
Return on capital %21.420.422.019.228.6 
Exports to sales %002.11.81.5 
Imports to sales %21.57.63.81.92.3 
Exports (fob) Rs m00428398339 
Imports (cif) Rs m4,0671,489786411510 
Fx inflow Rs m6322428398339 
Fx outflow Rs m4,0671,489786411510 
Net fx Rs m-4,004-1,466-358-14-171 
PFIZER CASH FLOW
From Operations Rs m 3,288 3,318 978 3,232 4,273 
From Investments Rs m -2,496 -2,383 351 15,303 -4,688 
From Financial Activity Rs m -826 -1,104 -1,099 -1,635 -15,711 
Net Cashflow Rs m -35 -169 231 16,900 -16,126 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 63.9%
Indian inst/Mut Fund 16.9%
FIIs 2.0%
ADR/GDR 0.0%
Free float 36.1%
Shareholders 131,308
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF The Capital 1802/1901, Plot No.c-70 G Block, Bandra Kurla Complex Bandra (East), Mumbai - 400051
E-MAIL contactus.india@pfizer.com WEB www.pfizerindia.com
TEL 91 22 6693 2000 FAX 91 22 2654 0274
SECTOR PHARMACEUTICALS GROUP Pfizer - MNC
TR AGENT K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
AUDITOR B S R & Co. LLP
CHM: R. A. Shah COMP SEC: Prajeet Nair YEAR OF INC: 1950 BSE CODE: 500680 FV (Rs): 10 DIV YIELD (%): 0.6

Read: PFIZER 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   IND SWIFT LA  FORTIS MALAR  BACIL PHARMA  KOVAI MEDICAL  FERMENTA BIOTECH  

Compare PFIZER With:   IND SWIFT LA  FORTIS MALAR  BACIL PHARMA  KOVAI MEDICAL  FERMENTA BIOTECH  




Today's Market

Sensex Ends 123 Points Higher; Bharti Airtel and Eicher Motors Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Views on news

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Krsnaa Diagnostics IPO Opens Tomorrow: Key Points to Consider (Views On News)

Aug 3, 2021

Krsnaa Diagnostics grey market premium is at around Rs 440 from its issue price of Rs 933-954.

Windlas Biotech IPO to Hit the Market on 4 August. Key Points to Know (Views On News)

Jul 31, 2021

Windlas Biotech IPO to open for subscription next week. Price band fixed at Rs 448-460.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

More Views on News

Most Popular

These Stocks Are Ready to Zoom (Fast Profits Daily)

Aug 3, 2021

These stocks are the best from a traders point of view.

A Trading Hack to Multiply Profits (Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks (Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

Devyani International IPO: Key Points to Consider (Views On News)

Jul 31, 2021

Its raining IPOs as 4 public issues open next week on the same day. Which one will you subscribe to?

A Rare Opportunity for Long-Term Investors Amid the Rout in China's Tech Stocks (Profit Hunter)

Jul 29, 2021

The epicentre of a tech-bubble led market crash in 2021 is closer than you think.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK PFIZER

MORE ON PFIZER

PFIZER - ALKEM LABORATORIES COMPARISON

COMPARE PFIZER WITH

MARKET STATS